Listed

Bicycle Therapeutics plc

BCYCNasdaqCIK 1761612HealthcareFiscal year ends Dec 31

Reports and events: 146 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Bicycle Therapeutics plc, Reports and events
FiledFormWhat it isAccession number
2026-10-2907:12 ET10-QQuarterly reportPeriod 2026-09-300001104659-26-119864
2026-10-2907:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-26-119858
2026-08-2016:05 ET8-K5.02 Departure or appointment of officers or directors0001104659-26-099221
2026-07-3007:10 ET10-QQuarterly reportPeriod 2026-06-300001104659-26-088457
2026-07-3007:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-26-088455
2026-06-1808:21 ET8-K5.07 Shareholder vote results0001104659-26-075451
2026-05-2117:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-065231
2026-04-3007:10 ET10-QQuarterly reportPeriod 2026-03-310001104659-26-052117
2026-04-3007:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-26-052107
2026-04-2216:05 ETDEF 14AProxy statementPeriod 2026-06-170001104659-26-046806
2026-04-2007:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-045198
2026-03-1707:19 ET10-KAnnual reportPeriod 2025-12-310001104659-26-028971
2026-03-1707:05 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-26-028954
2026-02-0307:07 ET8-K5.02 Departure or appointment of officers or directors0001104659-26-009501
2026-01-1207:12 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-002706
2025-10-3007:16 ET10-QQuarterly reportPeriod 2025-09-300001104659-25-104010
2025-10-3007:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-25-104004
2025-09-0816:01 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-25-088238
2025-08-0807:14 ET10-QQuarterly reportPeriod 2025-06-300001558370-25-010843
2025-08-0807:05 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-25-075435
2025-06-1717:08 ET8-K5.07 Shareholder vote results0001104659-25-060316
2025-05-0107:10 ET10-QQuarterly reportPeriod 2025-03-310001558370-25-006049
2025-05-0107:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-25-043014
2025-04-2907:22 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-25-040625
2025-04-2316:03 ETDEF 14AProxy statementPeriod 2025-06-170001558370-25-005258
2025-03-2708:02 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-25-028531
2025-03-1416:01 ET8-K5.08 Item not in the standard list0001104659-25-023934
2025-02-2507:27 ET10-KAnnual reportPeriod 2024-12-310001558370-25-001438
2025-02-2507:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-25-016709
2025-01-1316:01 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-25-003026
2024-12-1718:46 ETSC 13D/AOwnership report, active investor, amended0001104659-24-129475
2024-12-1309:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-24-128241
2024-10-3107:20 ET10-QQuarterly reportPeriod 2024-09-300001558370-24-014004
2024-10-3107:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-24-112848
2024-10-2309:01 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-24-110749
2024-09-1908:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-24-101202
2024-08-0607:40 ET10-QQuarterly reportPeriod 2024-06-300001558370-24-010949
2024-08-0607:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-24-086085
2024-07-1016:50 ET8-K1.02 Termination of a material agreement0001104659-24-078976
2024-06-1816:18 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-24-072828
2024-05-2816:16 ETSC 13D/AOwnership report, active investor, amended0001104659-24-065602
2024-05-2316:26 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-24-064716
2024-05-1616:01 ET8-K5.07 Shareholder vote results0001104659-24-062503
2024-05-0207:15 ET10-QQuarterly reportPeriod 2024-03-310001558370-24-006453
2024-05-0207:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-24-055981
2024-04-1807:29 ETSC 13DOwnership report, active investor0001104659-24-048601
2024-04-1807:00 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-24-048576
2024-04-1516:05 ETDEF 14AProxy statementPeriod 2024-05-160001558370-24-005119
2024-02-2007:19 ET10-KAnnual reportPeriod 2023-12-310001558370-24-001324
2024-02-2007:05 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-24-025196

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 07:25 ET. Listed shows no prices and gives no investment advice.